DK3400019T3 - CNP-prodrugs med bærerbinding ved ringenheden - Google Patents
CNP-prodrugs med bærerbinding ved ringenheden Download PDFInfo
- Publication number
- DK3400019T3 DK3400019T3 DK17700496.7T DK17700496T DK3400019T3 DK 3400019 T3 DK3400019 T3 DK 3400019T3 DK 17700496 T DK17700496 T DK 17700496T DK 3400019 T3 DK3400019 T3 DK 3400019T3
- Authority
- DK
- Denmark
- Prior art keywords
- ring unit
- carrier attachment
- cnp prodrugs
- cnp
- prodrugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16150625 | 2016-01-08 | ||
| EP16179288 | 2016-07-13 | ||
| EP16191460 | 2016-09-29 | ||
| PCT/EP2017/050209 WO2017118698A1 (en) | 2016-01-08 | 2017-01-05 | Cnp prodrugs with carrier attachment at the ring moiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3400019T3 true DK3400019T3 (da) | 2022-10-24 |
Family
ID=57821955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17700496.7T DK3400019T3 (da) | 2016-01-08 | 2017-01-05 | CNP-prodrugs med bærerbinding ved ringenheden |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11413351B2 (da) |
| EP (2) | EP3400019B1 (da) |
| JP (2) | JP6968802B2 (da) |
| AU (4) | AU2017205688C1 (da) |
| CA (1) | CA3007979C (da) |
| DK (1) | DK3400019T3 (da) |
| ES (1) | ES2934582T3 (da) |
| HR (1) | HRP20221339T1 (da) |
| HU (1) | HUE060521T2 (da) |
| LT (1) | LT3400019T (da) |
| PL (1) | PL3400019T3 (da) |
| RS (1) | RS63793B1 (da) |
| SI (1) | SI3400019T1 (da) |
| SM (1) | SMT202200466T1 (da) |
| WO (1) | WO2017118698A1 (da) |
| ZA (1) | ZA201804415B (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10835578B2 (en) * | 2016-01-08 | 2020-11-17 | Ascendis Pharma Growth Disorders A/S | CNP prodrugs with large carrier moieties |
| AU2017205688C1 (en) | 2016-01-08 | 2022-03-10 | Ascendis Pharma Growth Disorders A/S | Cnp prodrugs with carrier attachment at the ring moiety |
| CA3008017C (en) | 2016-01-08 | 2024-01-02 | Ascendis Pharma Growth Disorders A/S | Controlled-release cnp agonists with reduced side-effects |
| NZ743488A (en) | 2016-01-08 | 2023-02-24 | Ascendis Pharma Growth Disorders As | Controlled-release cnp agonists with low initial npr-b activity |
| AU2017205694B2 (en) * | 2016-01-08 | 2022-05-26 | Ascendis Pharma Growth Disorders A/S | Controlled-release CNP agonists with low NPR-C binding |
| AU2017205690B2 (en) | 2016-01-08 | 2022-04-28 | Ascendis Pharma Growth Disorders A/S | Controlled-release CNP agonists with increased NEP stability |
| HRP20230385T1 (hr) | 2016-09-29 | 2023-06-23 | Ascendis Pharma Growth Disorders A/S | Kombinirana terapija sa cnp agonistima s kontroliranim oslobađanjem |
| AU2018231832A1 (en) | 2017-03-10 | 2019-08-08 | Quiapeg Pharmaceuticals Ab | Releasable conjugates |
| EP3849660A1 (en) | 2018-09-12 | 2021-07-21 | QuiaPEG Pharmaceuticals AB | Releasable glp-1 conjugates |
| EP3923906A1 (en) | 2019-02-11 | 2021-12-22 | Ascendis Pharma Growth Disorders A/S | Dry pharmaceutical formulations of cnp conjugates |
| WO2021055497A1 (en) * | 2019-09-16 | 2021-03-25 | Biomarin Pharmaceutical Inc. | Cnp variants and conjugates thereof |
| JP7837333B2 (ja) * | 2020-11-25 | 2026-03-30 | プロリンクス エルエルシー | Ｃ－ナトリウム利尿ペプチドの徐放性ヒドロゲルコンジュゲート |
| WO2023227505A1 (en) | 2022-05-23 | 2023-11-30 | Ascendis Pharma Growth Disorders A/S | Liquid pharmaceutical formulations of cnp compounds |
| US12077561B2 (en) * | 2022-11-02 | 2024-09-03 | Novo Nordisk A/S | CNP compounds |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2226575C (en) | 1995-07-27 | 2011-10-18 | Genentech, Inc. | Stabile isotonic lyophilized protein formulation |
| US6624142B2 (en) | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
| CN1169573C (zh) | 1998-09-28 | 2004-10-06 | 参天制药株式会社 | 用于治疗角结膜障碍的、包含作为活性组分的钠尿肽的泪液分泌促进剂或滴眼剂 |
| PE20010212A1 (es) | 1999-06-01 | 2001-02-22 | Neuralab Ltd | Composiciones del peptido a-beta y procesos para producir las mismas |
| BRPI0203172B8 (pt) | 2001-09-28 | 2021-05-25 | Nakao Kazuwa | composição farmacêutica para acondroplasia |
| EP2042196B1 (en) | 2001-10-10 | 2016-07-13 | ratiopharm GmbH | Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| US7122189B2 (en) | 2002-08-13 | 2006-10-17 | Enzon, Inc. | Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| BR0316560A (pt) * | 2002-11-26 | 2005-10-04 | Nobex Corp | Conjugado de composto natriurético, formulação farmacêutica, método de tratar uma condição, método de preparação do conjugado de composto natriurético, conjugado de peptìdeo pró-polinatriurético modificado, análogo de peptìdeo natriurético, análogo de hbnp, composto, e, método de preparar um composto |
| US7332164B2 (en) | 2003-03-21 | 2008-02-19 | Enzon Pharmaceuticals, Inc. | Heterobifunctional polymeric bioconjugates |
| CA2763817C (en) | 2003-04-08 | 2014-05-27 | Yeda Research And Development Co. Ltd. | Reversible pegylated drugs |
| CA2521784C (en) | 2003-04-08 | 2012-03-27 | Yeda Research And Development Co. Ltd. | Reversible pegylated drugs |
| WO2005099768A2 (en) | 2004-03-23 | 2005-10-27 | Complex Biosystems Gmbh | Polymeric prodrug with a self-immolative linker |
| GB2427360A (en) | 2005-06-22 | 2006-12-27 | Complex Biosystems Gmbh | Aliphatic prodrug linker |
| CU23556A1 (es) | 2005-11-30 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Estructura polimérica semejante a dendrímero para la obtención de conjugados de interés farmacéutico |
| US8450269B2 (en) | 2006-02-03 | 2013-05-28 | Prolor Biotech Ltd. | Long-acting growth hormone and methods of producing same |
| US9283260B2 (en) | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
| MX2009002504A (es) | 2006-09-08 | 2009-05-22 | Mayo Foundation | Polipeptidos acuareticos y natriureticos que carecen de actividad vasodilatadora. |
| MX2009002859A (es) | 2006-09-15 | 2009-03-30 | Enzon Pharmaceuticals Inc | Enlazadores biodegradables a base de ester impedido para suministro de oligonucleotidos. |
| TWI409081B (zh) | 2006-11-09 | 2013-09-21 | Alcon Res Ltd | 用於藥物輸送之水不溶性聚合物基質 |
| EP2829282B1 (en) | 2007-03-22 | 2017-10-25 | The Regents of The University of Colorado, A Body Corporate | Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
| KR20080098216A (ko) | 2007-05-04 | 2008-11-07 | 한미약품 주식회사 | 캐리어 물질을 이용한 나트륨 배설 펩타이드 약물 결합체 |
| JP5351889B2 (ja) | 2007-06-21 | 2013-11-27 | テクニシェ ユニバーシタット ミュンヘン | インビボおよび／またはインビトロ安定性が増大した生物学的に活性なタンパク質 |
| EP2175878A4 (en) | 2007-07-11 | 2014-12-03 | Belrose Pharma Inc | POLYMER DRUG DISPENSING SYSTEM WITH A MULTIPLE SUBSTITUTED AROMATIC PART |
| EP2217620A2 (en) | 2007-11-21 | 2010-08-18 | BioMarin Pharmaceutical Inc. | Variants of c-type natriuretic peptide |
| AU2008340304B2 (en) | 2007-12-21 | 2016-03-03 | Aptevo Biotherapeutics Llc | Stabilized factor IX formulations containing trehalose |
| CA2712224C (en) * | 2008-02-01 | 2016-03-08 | Ascendis Pharma As | Prodrug comprising a drug linker conjugate |
| US20110105413A1 (en) | 2008-05-23 | 2011-05-05 | Enzon Pharmaceuticals, Inc. | Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligonucleotides |
| KR20130018965A (ko) | 2008-05-23 | 2013-02-25 | 다이이찌 산쿄 가부시키가이샤 | 목적 펩타이드의 혈장내 반감기 연장 작용을 가진 펩타이드 |
| WO2009156481A1 (en) | 2008-06-25 | 2009-12-30 | Ascendis Pharma As | Pegylated bnp |
| WO2010033216A1 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of nesiritide peptides |
| CN108530543B (zh) | 2009-02-03 | 2023-06-23 | 阿穆尼克斯制药公司 | 延伸重组多肽和包含该延伸重组多肽的组合物 |
| HUE032582T2 (en) | 2009-05-20 | 2017-09-28 | Biomarin Pharm Inc | Variants of c-type natriuretic peptide |
| US9173953B2 (en) | 2009-07-31 | 2015-11-03 | Ascendis Pharma As | Prodrugs containing an aromatic amine connected by an amido bond to a linker |
| WO2011031441A1 (en) | 2009-08-28 | 2011-03-17 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Therapy with a chimeric molecule and a pro-apoptotic agent |
| CA2783296C (en) | 2009-12-15 | 2019-01-15 | Ascendis Pharma As | Growth hormone composition |
| WO2011075471A2 (en) | 2009-12-18 | 2011-06-23 | Alcon Research, Ltd. | Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders |
| US20120289571A1 (en) | 2009-12-31 | 2012-11-15 | Enzon Pharmaceuticals, Inc. | Polymeric conjugates of aromatic amine containing compounds including releasable urea linker |
| WO2011089214A1 (en) | 2010-01-22 | 2011-07-28 | Ascendis Pharma As | Carrier-linked carbamate prodrug linkers |
| WO2011089216A1 (en) | 2010-01-22 | 2011-07-28 | Ascendis Pharma As | Dipeptide-based prodrug linkers for aliphatic amine-containing drugs |
| WO2011089215A1 (en) | 2010-01-22 | 2011-07-28 | Ascendis Pharma As | Dipeptide-based prodrug linkers for aromatic amine-containing drugs |
| EP4450523A3 (en) | 2010-04-02 | 2025-03-12 | Amunix Pharmaceuticals, Inc. | Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same |
| WO2011140392A1 (en) | 2010-05-05 | 2011-11-10 | Prolynx Llc | Controlled drug release from solid supports |
| ES2584381T3 (es) | 2010-05-05 | 2016-09-27 | Prolynx Llc | Liberación controlada de compuestos activos desde conjugados macromoleculares |
| MX338914B (es) | 2010-05-21 | 2016-05-06 | Xl Protein Gmbh | Polipeptidos biosinteticos de espira aleatoria de prolina/alanina y sus usos. |
| AU2012296949B2 (en) | 2011-08-12 | 2016-09-15 | Ascendis Pharma A/S | High-loading water-soluble carrier-linked prodrugs |
| CA2843506C (en) | 2011-08-12 | 2020-05-12 | Ascendis Pharma A/S | Carrier-linked prodrugs having reversible carboxylic ester linkages |
| EP2741778A1 (en) | 2011-08-12 | 2014-06-18 | Ascendis Pharma A/S | Polymeric hyperbranched carrier-linked prodrugs |
| EP2741781A1 (en) | 2011-08-12 | 2014-06-18 | Ascendis Pharma A/S | Carrier-linked treprostinil prodrugs |
| WO2013024049A1 (en) | 2011-08-12 | 2013-02-21 | Ascendis Pharma A/S | Protein carrier-linked prodrugs |
| WO2013036857A1 (en) * | 2011-09-07 | 2013-03-14 | Prolynx Llc | Sulfone linkers |
| AU2013254756B2 (en) | 2012-04-25 | 2017-03-30 | Ascendis Pharma A/S | Prodrugs of hydroxyl-comprising drugs |
| JPWO2013161895A1 (ja) | 2012-04-25 | 2015-12-24 | 第一三共株式会社 | 骨修復促進剤 |
| US10052366B2 (en) | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| JP6536871B2 (ja) | 2013-12-02 | 2019-07-03 | 国立大学法人京都大学 | Ｆｇｆｒ３病の予防および治療剤ならびにそのスクリーニング方法 |
| WO2015129812A1 (ja) | 2014-02-27 | 2015-09-03 | 第一三共株式会社 | ステロイド剤投与で誘発される成長障害に対する医薬 |
| CA2947396C (en) | 2014-04-28 | 2021-10-19 | Eisai R&D Management Co., Ltd. | Lyophilized formulation of hgf |
| EP3193941B1 (en) | 2014-08-06 | 2024-05-22 | Ascendis Pharma A/S | Prodrugs comprising an aminoalkyl glycine linker |
| CA2972318A1 (en) | 2015-01-09 | 2016-07-14 | Ascendis Pharma Growth Disorders A/S | Prodrugs of c-type natriuretic peptide(cnp) |
| CA2994280C (en) | 2015-07-30 | 2024-01-23 | Biomarin Pharmaceutical Inc. | Use of c-type natriuretic peptide variants to treat skeletal dysplasia |
| EP3386531B1 (en) | 2015-12-08 | 2021-10-13 | BioMarin Pharmaceutical Inc. | Use of c-type natriuretic peptide variants to treat osteoarthritis |
| AU2017205694B2 (en) | 2016-01-08 | 2022-05-26 | Ascendis Pharma Growth Disorders A/S | Controlled-release CNP agonists with low NPR-C binding |
| AU2017205690B2 (en) | 2016-01-08 | 2022-04-28 | Ascendis Pharma Growth Disorders A/S | Controlled-release CNP agonists with increased NEP stability |
| US10835578B2 (en) | 2016-01-08 | 2020-11-17 | Ascendis Pharma Growth Disorders A/S | CNP prodrugs with large carrier moieties |
| AU2017205688C1 (en) | 2016-01-08 | 2022-03-10 | Ascendis Pharma Growth Disorders A/S | Cnp prodrugs with carrier attachment at the ring moiety |
| CA3008017C (en) | 2016-01-08 | 2024-01-02 | Ascendis Pharma Growth Disorders A/S | Controlled-release cnp agonists with reduced side-effects |
| NZ743488A (en) | 2016-01-08 | 2023-02-24 | Ascendis Pharma Growth Disorders As | Controlled-release cnp agonists with low initial npr-b activity |
| HRP20230385T1 (hr) | 2016-09-29 | 2023-06-23 | Ascendis Pharma Growth Disorders A/S | Kombinirana terapija sa cnp agonistima s kontroliranim oslobađanjem |
| EP3836930A4 (en) | 2018-08-16 | 2022-05-11 | Beyondspring Pharmaceuticals Inc. | Method and composition for stimulating immune response |
| EP3923906A1 (en) | 2019-02-11 | 2021-12-22 | Ascendis Pharma Growth Disorders A/S | Dry pharmaceutical formulations of cnp conjugates |
-
2017
- 2017-01-05 AU AU2017205688A patent/AU2017205688C1/en active Active
- 2017-01-05 RS RS20221110A patent/RS63793B1/sr unknown
- 2017-01-05 JP JP2018535367A patent/JP6968802B2/ja active Active
- 2017-01-05 WO PCT/EP2017/050209 patent/WO2017118698A1/en not_active Ceased
- 2017-01-05 EP EP17700496.7A patent/EP3400019B1/en active Active
- 2017-01-05 EP EP22197366.2A patent/EP4162955A1/en active Pending
- 2017-01-05 LT LTEPPCT/EP2017/050209T patent/LT3400019T/lt unknown
- 2017-01-05 CA CA3007979A patent/CA3007979C/en active Active
- 2017-01-05 SM SM20220466T patent/SMT202200466T1/it unknown
- 2017-01-05 SI SI201731268T patent/SI3400019T1/sl unknown
- 2017-01-05 HR HRP20221339TT patent/HRP20221339T1/hr unknown
- 2017-01-05 ES ES17700496T patent/ES2934582T3/es active Active
- 2017-01-05 US US16/067,095 patent/US11413351B2/en active Active
- 2017-01-05 PL PL17700496.7T patent/PL3400019T3/pl unknown
- 2017-01-05 DK DK17700496.7T patent/DK3400019T3/da active
- 2017-01-05 HU HUE17700496A patent/HUE060521T2/hu unknown
-
2018
- 2018-07-02 ZA ZA2018/04415A patent/ZA201804415B/en unknown
-
2021
- 2021-10-27 JP JP2021175180A patent/JP7816947B2/ja active Active
- 2021-11-30 AU AU2021277638A patent/AU2021277638C1/en active Active
-
2022
- 2022-06-16 US US17/842,436 patent/US12156917B2/en active Active
-
2023
- 2023-08-02 AU AU2023210599A patent/AU2023210599B2/en active Active
-
2024
- 2024-10-25 US US18/927,578 patent/US20250121074A1/en active Pending
- 2024-12-11 AU AU2024278289A patent/AU2024278289A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201804415B (en) | Cnp prodrugs with carrier attachment at the ring moiety | |
| AU201613881S (en) | Flashlight | |
| IL261624B (en) | Carbide with toughness-increasing structure | |
| AU201613867S (en) | Flashlight | |
| ZA201804414B (en) | Cnp prodrugs with large carrier moieties | |
| AU201613874S (en) | Flashlight | |
| AU201613863S (en) | Flashlight | |
| AU201613880S (en) | Flashlight | |
| AU201613878S (en) | Flashlight | |
| AU201613879S (en) | Flashlight | |
| GB201603056D0 (en) | Ring clip | |
| GB2555153B (en) | Mounting arrangement | |
| GB201502140D0 (en) | Wheel within the wheel | |
| EP3724416C0 (fr) | Lisse à parties détachables | |
| PL3336277T3 (pl) | Element nośny części dystansowych | |
| GB201707505D0 (en) | Attachment arrangement | |
| GB2549084B (en) | Fixing | |
| PT3400019T (pt) | Pró-fármacos de cnp com ligação de transportador na unidade de anel | |
| AU201810442S (en) | Powerbank with torch | |
| GB201711739D0 (en) | The in-soap piece | |
| FI11554U1 (fi) | Kantolaite | |
| GB201720386D0 (en) | The twizzler | |
| FI11960U1 (fi) | Uurnan kantolaite | |
| GB201717702D0 (en) | The Privvy | |
| GB201621249D0 (en) | Brace assembly |